TERRAMYCIN W/ POLYMYXIN B SULFATE
LOE Approachingoxytetracycline hydrochloride; polymyxin b sulfate
NDAOPHTHALMICOINTMENT
Approved
Jul 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Terramycin w/ Polymyxin B Sulfate is a fixed-dose combination ophthalmic ointment containing oxytetracycline hydrochloride (a tetracycline antibiotic) and polymyxin B sulfate (a polymyxin antibiotic) for treatment of bacterial eye infections. It provides broad-spectrum coverage against gram-positive, gram-negative, and some atypical organisms. This product is indicated for superficial ocular infections where dual antibiotic coverage is clinically beneficial.
LOE Approaching
This legacy product faces increasing generic/OTC competition (30% competitive pressure) with minimal current job growth and likely shrinking team size as LOE approaches.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Terramycin offers limited near-term career growth due to approaching LOE, minimal linked job openings, and mature market dynamics. This role is best suited for professionals seeking cost-management, compliance, or legacy-product stewardship experience rather than launch or expansion opportunities.
Brand ManagerMedical Science Liaison
Worked on TERRAMYCIN W/ POLYMYXIN B SULFATE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.